Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
Nature Medicine2004Vol. 10(12), pp. 1344–1351
Citations Over TimeTop 1% of 2004 papers
Weijia Kong, Jing Wei, Parveen Abidi, Meihong Lin, Satoru Inaba, Cong Li, Yanling Wang, Zizheng Wang, Shuyi Si, Huai-Ning Pan, Shukui Wang, Jingdan Wu, Yue Wang, Zhuorong Li, Jingwen Liu, Jian‐Dong Jiang
Related Papers
- → On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects(2014)80 cited
- Antilipemic Effect of Berberine Combined with Atorvastatin on Rats with Hypelipemia(2014)
- The therapeutical and pharmacological action of atorvastatin for familial hypercholesterolemia(2006)
- → LDLR, PCSK9, and LDLRAP1 mutations in the same patient in a familial hypercholesterolemia (FH) family(2017)
- → Development and functional analysis of novel PCSK9/LDLR interaction inhibitors for hypercholesterolemia treatment(2021)